GORDIAN BIOTECHNOLOGY, INC.
San Francisco, CA · Biotech · Private
Whole genome sequencing and RNA profiling platform for predicting individual variation in drug metabolism and toxicity across diverse human cell populations
gordian.bio →- Grants
- $2.4M
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 1 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · In Vitro Toxicity Testing at Massive Scale in Diverse Primary Human Cells | $1,622,746 | |
| Federal grant | Department of Health and Human Services · Phase II · In Vitro Toxicity Testing at Massive Scale in Diverse Primary Human Cells | $811,373 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1976 | VLP THERAPEUTICS, INC. | — | — |
| 1977 | CILA THERAPEUTIC INC. | — | — |
| 1978 | Liberation Technology Services, Inc. | — | $25K |
| 1979 | GORDIAN BIOTECHNOLOGY, INC. | — | — |
| 1980 | ARCATO LABORATORIES, INC. | — | — |
| 1981 | Corxel | — | — |
| 1982 | CytomX Therapeutics | — | $143M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions And Methods For In Vivo Screening Of Therapeuticsapplication
- Compositions And Methods For In Vivo Screening Of Therapeutics Using Single Nucleus Sequencingapplication
- Methods And Compositions For In Vivo Screening Of Therapeutics Through Spatial Transcriptomicsgranted
- Viral Delivery Vehicle Selectionapplication
- Compositions And Methods For In Vivo Screening Of Therapeuticsapplication
- Viral Delivery Vehicle Selectionapplication
- Methods And Compositions For In Vivo Screening Of Therapeutics Through Spatial Transcriptomicsapplication
- Compositions And Methods For In Vivo Screening Of Therapeuticsapplication
- Viral Delivery Vehicle Selectionapplication
- Compositions And Methods For In Vivo Screening Of Therapeuticsapplication
- Compositions And Methods For In Vivo Screening Of Therapeuticsapplication
- Compositions And Methods For In Vivo Screening Of Therapeutics Using Single Nucleus Sequencingapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.